Julio Wainstein

Medicine & Life Sciences

1. 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol 9%
2. Acarbose 8%
3. Appetite 7%
4. Blood Glucose 31%
5. Body Weight 7%
6. Breakfast 33%
7. C-Peptide 7%
8. Chronic Renal Insufficiency 11%
9. Circadian Clocks 10%
10. Diabetes Complications 8%
11. Diabetes Mellitus 14%
12. Diet 10%
13. Elderly 8%
14. Energy Intake 7%
15. Fasting 17%
16. Functional Food 7%
17. Gastroparesis 12%
18. Genes 7%
19. Glucagon-Like Peptide 1 8%
20. Glucose 50%
21. Hospitalization 14%
22. Hyperglycemia 21%
23. Hypoglycemia 31%
24. Hypoglycemic Agents 16%
25. Incidence 8%
26. Insulin 35%
27. Insulin Glargine 8%
28. Internal Medicine 16%
29. Israel 8%
30. Length of Stay 8%
31. Life Style 9%
32. Lunch 11%
33. Meals 27%
34. Metformin 7%
35. Mitochondrial DNA 9%
36. Mortality 10%
37. N,N-dimethylarginine 8%
38. olive extract 10%
39. Placebos 29%
40. Population 12%
41. Randomized Controlled Trials 17%
42. Safety 14%
43. Serum 10%
44. Sitagliptin Phosphate 16%
45. Therapeutics 16%
46. TRPV1 receptor 7%
47. Type 1 Diabetes Mellitus 17%
48. Type 2 Diabetes Mellitus 100%
49. Weight Loss 15%
50. Whey Proteins 8%